T1	Participants 48 64	healthy subjects
T2	Participants 102 169	Patients suffering from some psychiatric and neurological disorders
T3	Participants 327 354	patients with schizophrenia
T4	Participants 418 478	patients which suggests that such eye movement abnormalities
T5	Participants 520 640	The psychopharmacology of saccadic distractibility is less well understood, but is relevant both to interpreting patient
